Showing 20 of 162 recruiting trials for “nasopharyngeal-carcinoma”
TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer
🏥 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)📍 1 site📅 Started Mar 2022View details ↗
Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy
RecruitingNCT05126160 ↗
Immune Score Based Radiomics in Nasopharyngeal Carcinoma
👨⚕️ Xiaozhong Chen, Department of Radiation Oncology, Zhejiang Cancer Hospital📍 5 sites📅 Started Nov 2021View details ↗
ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma
Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.
Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC
👨⚕️ Xiaolin GE, MM, The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Jun 2021View details ↗
Fluorescence Image Guided Foregut Surgery
👨⚕️ Silvana PERRETTA, MD, PhD, Service de Chirurgie Digestive et Endocrinienne, NHC, Strasbourg📍 1 site📅 Started Apr 2021View details ↗
RecruitingNCT07080437 ↗
An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma
RecruitingNCT04455282 ↗
CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1
👨⚕️ Nikolas Stoecklein, MD, Surgery, University Hospital Düsseldorf Germany📍 2 sites📅 Started Feb 2021View details ↗
Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
RAMIE Versus MIE for Resectable Esophageal Cancer, a Randomized Controlled Trial (ROBOT-2 Trial).
👨⚕️ Peter Grimminger, MD,PhD, JGU Medizin Mainz, dept. AVTC📍 1 site📅 Started Jan 2021View details ↗
TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY
👨⚕️ Hanneke WM van Laarhoven, MD,PhD, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)📍 1 site📅 Started Nov 2020View details ↗
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma
Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
👨⚕️ Jinquan Liu, M.D, Affiliated Cancer Hospital & Institute of Guangzhou Medical University📍 1 site📅 Started Aug 2020View details ↗
Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma
Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →